Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1965 Sep;54(3):946–953. doi: 10.1073/pnas.54.3.946

The inhibition of vaccinia virus multiplication by isatin-beta-thiosemicarbazone.

B Woodson, W K Joklik
PMCID: PMC219769  PMID: 5217472

Full text

PDF
946

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BACH M. K., MAGEE W. E. Biochemical effects of isatin beta-thiosemicarbazone on development of vaccinia virus. Proc Soc Exp Biol Med. 1962 Jul;110:565–567. doi: 10.3181/00379727-110-27580. [DOI] [PubMed] [Google Scholar]
  2. BAUER D. J. The chemotherapy of ectromelia infection with isatin beta-dialkylthiosemicarbazones. Br J Exp Pathol. 1963 Apr;44:233–242. [PMC free article] [PubMed] [Google Scholar]
  3. BECKER Y., JOKLIK W. K. MESSENGER RNA IN CELLS INFECTED WITH VACCINIA VIRUS. Proc Natl Acad Sci U S A. 1964 Apr;51:577–585. doi: 10.1073/pnas.51.4.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. JOKLIK W. K., BECKER Y. THE REPLICATION AND COATING OF VACCINIA DNA. J Mol Biol. 1964 Dec;10:452–474. doi: 10.1016/s0022-2836(64)80066-8. [DOI] [PubMed] [Google Scholar]
  5. JOKLIK W. K. The preparation and characteristics of highly purified radioactively labelled poxvirus. Biochim Biophys Acta. 1962 Aug 20;61:290–301. doi: 10.1016/0926-6550(62)90091-9. [DOI] [PubMed] [Google Scholar]
  6. JOKLIK W. K. The purification fo four strains of poxvirus. Virology. 1962 Sep;18:9–18. doi: 10.1016/0042-6822(62)90172-1. [DOI] [PubMed] [Google Scholar]
  7. LINDENMANN J., GIFFORD G. E. Studies on vaccinia virus plaque formation and its inhibition by interferon. I. Dynamics of plaque formation by vaccinia virus. Virology. 1963 Mar;19:283–293. doi: 10.1016/0042-6822(63)90066-7. [DOI] [PubMed] [Google Scholar]
  8. O'SULLIVAN D. G., SA DLER P. W. Agents with high activity against type 2 poliovirus. Nature. 1961 Oct 28;192:341–343. doi: 10.1038/192341a0. [DOI] [PubMed] [Google Scholar]
  9. SHEFFIELD F. W. Inhibition of rabbitpox virus replication by isatin beta-thiosemicarbazone. Br J Exp Pathol. 1962 Feb;43:59–66. [PMC free article] [PubMed] [Google Scholar]
  10. THOMPSON R. L., DAVIS J., RUSSELL P. B., HITCHINGS G. H. Effect of aliphatic oxime and isatin thisemicarbazones on vaccinia infection in the mouse and in the rabbit. Proc Soc Exp Biol Med. 1953 Nov;84(2):496–499. doi: 10.3181/00379727-84-20690. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES